{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities#webpage",
"url": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities",
"name": "The power of RWD in clinical development and post-market activities",
"description": "Explore this Fortrea white paper on real-world data (RWD) and real-world evidence (RWE) strategies in clinical development and discover how healthcare organizations are using real-world insights to strengthen evidence generation, improve decision-making, and optimize development outcomes across the product lifecycle. The white paper examines the growing role of real-world data in clinical research, regulatory-grade evidence generation, patient outcomes analysis, healthcare analytics, and market access planning while highlighting how integrated healthcare datasets and observational research approaches can support more informed clinical and commercial strategies. Learn how RWD-driven clinical development, decentralized evidence generation, longitudinal patient data analysis, and advanced healthcare analytics are helping sponsors improve trial optimization, support regulatory interactions, enhance payer value demonstration, and strengthen long-term evidence planning across modern healthcare and pharmaceutical development programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities",
"item": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/power-rwd-clinical-development-and-post-market-activities#webpage"
},
"headline": "Real-World Data & Evidence Strategies in Clinical Development | Fortrea White Paper",
"description": "Explore this Fortrea white paper on real-world data (RWD) and real-world evidence (RWE) strategies in clinical development and discover how healthcare organizations are using real-world insights to strengthen evidence generation, improve decision-making, and optimize development outcomes across the product lifecycle. The white paper examines the growing role of real-world data in clinical research, regulatory-grade evidence generation, patient outcomes analysis, healthcare analytics, and market access planning while highlighting how integrated healthcare datasets and observational research approaches can support more informed clinical and commercial strategies. Learn how RWD-driven clinical development, decentralized evidence generation, longitudinal patient data analysis, and advanced healthcare analytics are helping sponsors improve trial optimization, support regulatory interactions, enhance payer value demonstration, and strengthen long-term evidence planning across modern healthcare and pharmaceutical development programs.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-12-23",
"dateModified": "2024-12-23",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/autoimmune-phase-1-trials-review.pdf",
"encodingFormat": "application/pdf"
}
}
]
}